The Australian Federal Court sentences a family-owned Australian pharmaceutical company and its former export manager for engaging in criminal cartel conduct, based on an investigation by the Competition Authority (Alkaloids)

KEYWORDS
Reference

Australian Competition Authority, Alkaloids, Press release, 29 November 2022

Alkaloids of Australia and its former export manager sentenced in criminal price fixing cartel* The Federal Court has sentenced a family-owned Australian pharmaceutical company and its former export manager for engaging in criminal cartel conduct, following a criminal prosecution by the Commonwealth Director of Public Prosecutions, that arose from an investigation by the ACCC. Alkaloids of Australia, which produces scopolamine N-butylbromide (SNBB), the active pharmaceutical ingredient used in common anti-spasmodic medications, was convicted and fined $1,987,500. Its former export manager, Christopher Kenneth Joyce, was also convicted and was

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Australian Competition Authority, The Australian Federal Court sentences a family-owned Australian pharmaceutical company and its former export manager for engaging in criminal cartel conduct, based on an investigation by the Competition Authority (Alkaloids), 29 November 2022, e-Competitions Criminal sanctions, Art. N° 109813

Visites 90

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues